Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal co-dominant monogenic disorder ...

New data links the liver receptor GPR110 to sex-specific progression of metabolic dysfunction-associated steatohepatitis.

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Right now, patients with obesity and cirrhosis ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical ...

Newly discovered mechanism by which oral bacteria affect gut health coincides with worsening liver health in patients with ...

New analysis shows alcohol-related liver disease remains a major cause of cirrhosis and liver death. Read more.

The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

Fatty liver disease is a health condition in which fat builds up in the liver. This fat buildup can cause inflammation and, in severe cases, liver damage. There are two main types of fatty liver ...

Fatty liver disease is not restricted to adults, and its incidence in children and adolescents is continuously increasing.